Article

Implications of Healthcare Reform Highlight AJPB Week in Review

Author(s):

AJPB staff

Top articles of the week from The American Journal of Pharmacy Benefits.

Related Videos
3 experts are featured in this series.
3 experts are featured in this series.
Related Content
Sleepless, man suffering from insomnia, sleep apnea or stress. Tired and exhausted guy. Headache or migraine. Awake in the night.
December 20th 2024

FDA Approves Tirzepatide as First Treatment for Moderate-to-Severe Obstructive Sleep Apnea in Adults With Obesity

Luke Halpern, Assistant Editor
Site Logo
December 20th 2024

Examining the 505(b)(2) Pathway and Implementation into EHR

Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA
FDA Approval, Weight Loss, Pediatrics | Image Credit: Aquir | stock.adobe.com
December 20th 2024

FDA Approves Expanded Indication for Setmelanotide to Include Patients 2 and Older

Ashley Gallagher, Associate Editor
Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments
November 25th 2024

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

Colorectal cancer cells under microscope | Image Credit: © Navaporn - stock.adobe.com
December 20th 2024

Encorafenib With Cetuximab and mFOLFOX6 Receives Accelerated Approval for Patients With Metastatic Colorectal Cancer

Alexandra Gerlach, Associate Editor
Close up image of skin texture suffering severe urticaria or hives or kaligata on back.
December 20th 2024

Patients With Chronic Idiopathic Urticaria at Higher Risk of Developing Food Allergies

Luke Halpern, Assistant Editor